Stress-dependent antinociceptive effects of carbamazepine: A study in stressed and nonstressed rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 22, Issue 1, 1998, Pages 159-168

  Mashimoto, Shigeki ^a   Ushijima, Itsuko ^a   Suetsugi, Masatomo ^a   Akimoto, Takashi ^a   Watanabe, Katsumi ^a   Yamada, Michio ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antinociception; Carbamazepine; Opioid system; Purinergic system; Stressed rats

Indexed keywords

ADENOSINE A1 RECEPTOR; CAFFEINE; CARBAMAZEPINE; CYCLOHEXYLADENOSINE; NALOXONE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; STRESS; TAIL FLICK TEST;

ADENOSINE; ANALGESICS, NON-NARCOTIC; ANALYSIS OF VARIANCE; ANIMALS; CAFFEINE; CARBAMAZEPINE; CEREBRAL VENTRICLES; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; NALOXONE; PAIN; PHYSICAL STIMULATION; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 0031883409     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(97)00186-3     Document Type: Article

References (27)

1. AKIL, H., MADDEN, J., PATRICK, R. L. and BARCHAS, J. D. (1978) Stress-induced increase in endogenous opiate peptides; concurrent analgesia and its partial reversal by naloxone. In: Opiates and Endogenous Opiate Peptides. H. W. Kosterlitz (Ed), pp. 53-70, North-Holland: Amsterdam
2. 3H]-cyclohexyl-adenosine binding to rat brain membranes. Pharmacol. Biochem. Behav. 26: 829-832.
3. BLOM, S. (1962) Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883). Lancet 1: 830-840.
4. BRUNS, R.F., LU, G.H. and PUGSLEY, T.A. (1987) Adenosine receptor subtypes: Binding studies. In: Topics and Perspectives in Adenosine Research, E. Gerlach and B.F. Becker (Eds), p. 59. Springer, Berlin.
5. DALY, J.W., BRUNS, R.F. and SNYDER, S.H. (1981) Adenosine receptor in the central nervous system: Relationship to the central actions of methylxanthines. Life Sci. 28: 2083-2097.
6. DAVAL, J.-L., DECKER T. J., WEISS, S. R. B., POST, R. M. and MARANGOS, P. J. (1989) Upregulation of adenosine A1-receptors and forskolin binding sites following chronic treatment with caffeine or carbamazepine: A quantitative autoradiographic study. Epilepsia 30: 26-33.
7. ELPHICK, M. (1989) Clinical issues in the use of carbamazepine in psychiatry: A review. Psychol. Med. 19: 591-604.
8. ELPHICK, M., TAGHAVI, Z., POWELL, T. and GODFREY, P. P. (1988) Alteration of inositol phospholipid metabolism in rat cortex by lithium but not carbamazepine. Eur. J. Pharmacol. 156: 411-414.
9. GINTZLER, A. R. and MUSACCHIO, J. M. (1975) Interactions of morphine, adenosine, adenosine triphosphate and phosphodiesterase inhibitors on the field-stimilated guinea pig ileum. J. Pharmacol. Exp. Ther. 194: 575-582.
10. HO, I.K., LOH, H. H. and WAY, E. L. (1973) Cyclic adenosine monophosphate antagonism of morphine analgesia. J. Pharmacol. Exp. Ther. 185: 336-346.
11. LONDOS, C., COOPER, D. M. and WOLFF, J. (1980) Subclasses of external adenosine receptors. Proc. Natl. Acad. Sci. USA, 77: 2551-2554.
12. MADDEN, J., AKIL, H., PATRICK, R. L. and BARCHAS, J. D. (1977) Stress-induced parallel changes in central opioid levels and pain responsiveness in the rat. Nature (Lond.) 265: 358-360.
13. MARANGOS, P. J., POST, R. M., PATEL, J., ZANDER, K., PARMA, A. and WEISS, S. (1983) Specific and potent interactions of carbamazepine with brain adenosine receptorsEur. J. Pharmacol 93: 175-182.
14. MARANGOS, P. J., PATEL, J., SMITH, K. D. and POST, R. M. (1987) Adenosine antagonist properties of carbamazepine. Epilepsia 28: 387-394.
15. MARANGOS, P. J., WEISS, S. R. B., MONTOGOMERY, P., PATEL, J., NARANG, P. K., CAPPABIANCA, A M. and POST, R. M. (1985) Persistent upregulation of brain adenosine receptors in response to chronic carbamazepine treatment. Epilepsia 26: 493-498.
16. POST, R. M. (1990) Sensitization and kindling perspectives for the course of affective illness: Toward a new treatment with the anticonvulsant carbamazepine. Pharmacopsychiatry 23: 3-17.
17. POST, R. M., UHDE, T. W., ROY-BYME, P. P. and JOFFE, R. T. (1986) Antidepressant effects of carbamazepine. Am. J. Psychiatry 143: 29-34.
18. SAWYNOK, J. and JHAMANDAS, K.H. (1976) Inhibition of acetylcholine release from cholinergic nerves by adenosine, adenine nucleotides and morphine; Antagonism by theophylline. J. Pharmacol. Exp. Ther. 197: 379-390.
19. SKERRITT, J.H., DAVIES, L.H. and JOHONSTO, G.A.R. (1983) Interactions of the anticonvulsant carbamazepine with adenosine receptors: 1. Neurochemical Studies. Epilepsia. 24: 634-642.
20. SNYDER, S.H. (1985) Adenosine as a neuromodulator. Annu. Rev. Neurosci. 8: 103-124.
21. SNYDER, S. H., KATIMS, J. J. A., NNAU, Z. BRUNS, R. F. and DALY, J. W. (1981) Adenosine receptors and behavioral actions of methylxanthines. Porc. Nat. Acad. Sci. U.S.A. 78: 3260-3264.
22. TANAKA, M., KOHNO, Y., TSUDA, A., NAKAGAWA, R., IDA, Y., IIMORI, K., HOKAI, Y. and NAGASAKI, Y. (1983) Differential effects of morphine on noradrenaline release in brain regions of stressed and non-stressed rats. Brain Res. 275: 105-115.
23. VAN CALKER, D., MÜLLER, M. and HAMPRECHT, B. (1978) Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells. Nature (Lond.) 276: 839-841.
24. VAN CALKER, D., MÜLLER, M. and HAMPRECH, B. (1979) Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 33: 999-1005.
25. VAN CALKER, D., STEBER, R., KOLTZ, K.N. and GREIL, W. (1991) Carbamazepine distinguishes between adenosine receptors that mediate different second messenger responses. Eur. J. Pharmacol. 206: 285-290.
26. VAPAATALO, H., ONKEN, D., NEUVONEN, P.J. and WESTERMANN, E.(1975) Stereospecificity in some central and circulatory effects of phenylisopropyl adenosine (PIA). Arzneim. Forsch. 25: 407-410.
27. WEIR, R. L., PADGETT, W., DALY, J. W. and ANDERSON, S. M. (1984) Interaction of anticonvulsant drugs with adenosine receptors in the central nervous system. Epilepsia 25: 492-498.